Series B

Debt Financing

Others

Series C

Seed

Series A

Series D

Series E

Herzliya

Peter Fitzgerald

Michal Geva

Dani Goldsher

If you're ready to take your business to the next level with Triventures, we want to hear your pitch.

Investment in Startup

Triventures: A key player in technology. Learn about their portfolio and funding focus at Lucidity Insights.

Triventures

Triventures is a venture capital fund that invests in disruptive medical device and digital health companies that impact the quality and cost of healthcare

Caesarea

V-Wave

Biotechnology

Medical

Medical Device

Healthcare

V-WAVE was established in Israel with a focus on developing percutaneous implantable technologies for patients with chronic heart failure.  Technology designed by V-Wave, highlighted by its Ventura® Interatrial Shunt System, was designed to help heart failure patients with relief of symptoms, reduced hospitalizations, and improved quality of life.

Tel Aviv

TailorMed

Health Care

Wellness

Machine Learning

Fintech

TailorMed is a comprehensive, end-to-end platform designed to eliminate barriers along the entire medication journey, from affordability to access and adherence.

Brightside Health

Medisafe

Cala Health

AI/IoT

EyeYon

Day Zero Diagnostics

Grin

Future Family

BioProtect

ZingBox

Security

Genoox

Cardiva Medical

CathWorks

Colospan

OrthoSpace

MST Medical Surgery Technologies

Analytics

Lynx MD

Monogoto

Developer APIs

AngioSlide

FEMSelect

PayGround

BurnAlong

6over6

BioGaming

Apica Cardiovascular

CAESAREA, Israel and AGOURA, Calif., Dec. 16, 2021 /PRNewswire/ -- V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced today that it has successfully closed all remaining tranches of the Series C extension totaling $98M. The financing assures capital to complete the clinical trial for the VenturaÒ Interatrial Shunt for the treatment of advanced heart failure and submit a PMA subject to final data for Agency review. It further funds continued development of the V-Wave Ventura Shunt product pipeline including its proprietary adjustable size Magical™ shunt. The Ventura Shunt is currently being evaluated in an international, multicenter RELIEVE-HF randomized trial in patients with both reduced and preserved ejection fraction who are advanced NYHA Class II, Class III and ambulatory Class IV and  on  guideline directed medical therapies. The financing was led by Deerfield Management with participation from Aperture Venture Partners, BRM Group, Endeavour Vision, Johnson & Johnson Innovation - JJDC Inc., Pontifax, Pura Vida Investments, GHS Fund (Quark Venture LP), as well as Triventures and Israel Secondary Fund.

V-Wave Completes Financing of $98M from Syndicate of Leading Global Healthcare Investors

V-Wave Ltd., a Caesarea, Israel-based medical device, closed a Series C financing of $70m.

The round was led by Deerfield Management with participation from new investors healthcare funds Endeavour Vision, Quark Venture and Aperture Venture Partners and existing investors including strategic investors Johnson & Johnson Innovation (JJDC Inc.) and Edwards Lifesciences, along with BRM Group, Pontifax, Pura Vida Investments, TriVentures, BioStar Ventures, and Israel Secondary Fund.

V-Wave Closes $70M Series C Financing

V-Wave Ltd., a Caesarea, Israel-based medical device company that is developing a proprietary implantable, interatrial shunt for the treatment of heart failure (HF), completed a Series B financing of $28m.

Backers included new investors Johnson & Johnson Innovation – JJDC Inc., TriVentures, Pura Vida Investments and BioStar Ventures and existing investors BRM Group, Pontifax and Edwards Lifesciences.

V-Wave Completes $28M Series B Financing

Triventures

Funding Deals, by Startup Growth Stage

Funding Deals, by Region

No. of Portfolio Companies

Total No. of Investments Globally, by Year

We Invest in Startups in the Following Stages

Statistics

Sectors we invest in

Top 5 sectors we invest in

Portfolio Companies
or Investments

Executive Team Members

About

Legal

Social Media

Triventures

Funding Deals, by Startup Growth Stage

Funding Deals, by Region

No. of Portfolio Companies

Total No. of Investments Globally, by Year

We Invest in Startups in the Following Stages

Statistics

Sectors we invest in

Top 5 sectors we invest in

Portfolio Companies or Investments

Executive Team Members

About

Legal

Social Media

Portfolio Companies
or Investments